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ABSTRACT 
Proteins occupy more than 50% of the dry weight of the average human cell.  The 
proteins present in a given cell at a given time reflect the function and specialization of 
that cell.  In addition to the specialization of cells within the body leading to various 
normal protein states, protein ‘sub-states’ can be induced by various conditions such as 
infections or cancer [9,21].  These disease-induced protein sub-states result in both 
qualitative and quantitative differences in both ribosomal production of proteins and post-
translational modification of proteins [2].  Each disease-induced sub-state therefore has 
its own protein profile or signature.  For diseases such as cancer, which can easily 
progress undetected and whose manifestations have grave consequences, statistical 
comparisons of a patient’s protein profile with many cancer-state protein profiles can be 
made for early detection.  Two-dimensional-liquid chromatography-tandem mass 
spectrometry (2D-LC-MS/MS) holds much promise in the analysis of such disease-
induced protein profiles.  2D-LC-MS/MS uses two means of separation prior to online 
mass analysis, whereas one-dimensional (1D) methods use only one means of separation.  
The increased separation of a 2D system allows for much more complete mass analysis of 
proteins and results in the identification and characterization of many more proteins and 
modifications than with a 1D system [15].  By comparing patients’ protein profiles with a 
comprehensive proteomic database, 2D-LC-MS/MS could serve as the critical step in an 
efficient early-detection method for diseases such as cancer.  Before protein profiles can 
be accurately compared and linked with diseases, a standardized technique must be used, 
and mechanisms that account for experimental variations must be implemented.  The 2D-
LC-MS/MS technique proposed here is both very useful and can be standardized easily. 
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1) INTRODUCTION 
556,902 Americans died from cancer in the year 2003, with deaths from cancer in 2003 
constituting 22.7% of all deaths in the United States [8].  Cancer is the second leading 
cause of death in the United States and remains an illusive disease to researchers and 
health specialists.  Although it is known that certain lifestyle habits can lead to cancer 
(having a diet high in fat, smoking, and not protecting oneself from harmful UV radiation 
are some examples), many people are understandably reluctant to change their habits, 
because they are either not well enough informed, cannot easily foresee the consequences 
of their habits, or do not feel like investing their time and energy in monitoring their diets 
or habits.  To help our friends, there has been much work by organizations to reduce 
public ignorance toward the disease.  Additionally, many research groups around the 
world have been working diligently to find biological solutions to the cancer epidemic.  
There have been many high-impact findings about the detection, prevention, and 
treatment of the disease [4,22].  However, what is lacking in cancer research is a method 
for grouping all of the information into one complete, easily understandable collection.  
This task calls for a bioinformatics-based solution, in which a standardized analysis 
technique can be combined through a comprehensive user interface with an extensive 
database to compare a patient’s samples with other patients’ samples and use this 
information to detect for diseases such as cancer.  One analysis technique with versatile 
and universal functionality is the use of 2D-LC-MS/MS to analyze protein expression in 
humans.  It has been shown that many types of cancer involve major changes in the 
protein expression in cells, and therefore protein profiles that correspond to different 
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types of cancer can be recorded.  This has the potential for inexpensive, early detection of 
cancer and could thereby reduce the number of deaths from cancer. 
 
2) BIOLOGICAL OVERVIEW 
Before discussing procedures for 2D-LC-MS/MS that can reproducibly represent nearly 
all cellular proteins that are present, it is necessary to first review some fundamental facts 
regarding proteins’ locations, production, and functions within cells as well as other 
important cellular processes.  A typical eukaryotic cell contains, among many other 
things, some important locations where proteins are most abundant: inner and outer 
membranes, ribosomes, the nucleus, and the cytoplasm.  Within the nucleus, the DNA 
codes for nearly everything that happens within the organism—external/environmental 
factors account for everything else.  Specifically, certain segments of the DNA encode 
for the production of all proteins produced by the organism. 
 
2.1) CELL SPECIALIZATION 
Throughout the lifetime of a human, stem cells, which are highly abundant at the 
beginning of development, repeatedly reproduce until they eventually become divided 
into specialized groups of cells, such as skin cells, liver cells, blood cells, brain cells, or 
muscle cells [18].  There are on the order of 1014 specialized cells in an adult human 
[17].  The same DNA is present in all of the specialized cells as was present in the stem 
cells, with some exceptions, such as adult red blood cells.  As cells become more 
specialized, various factors influence the protein expression by causing certain parts of 
their DNA to become inactive and certain parts to become active.  The ways in which 
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DNA is packed in the nucleus plays a crucial role in determining what segments of the 
DNA are expressed.  Histones are a class of nuclear proteins involved in the packing of 
DNA that are very influential in determining what DNA segments are expressed during 
transcription [9,10,13,21].  Interestingly, certain segments of the DNA determine the 
structure of these histones, and these histones determine what DNA segments are 
expressed, thereby creating a feedback loop.  As the expressed segments of DNA become 
increasingly dependent on the cell’s function, corresponding protein changes occur.  It is 
through this process that the protein expression in a cell becomes very dependent on the 
function of the cell.  The following figure represents the differentiation of cells from stem 
cells as cells are called upon to serve various functions. 
 
FIGURE 2.1.1: Cell Differentiation in Human Tissues* 
 
*Figure from [17] 
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DNA within the nuclei of most human cells is estimated to encode for >30,000 different 
proteins [1].  However, the proteins that exist in any given cell at a given time are highly 
specific and represent only a small percentage of the possible proteins encoded by the 
DNA.  This select amount of proteins within each cell is on the order of magnitude of 10 
to 103 distinct proteins per cell.  In addition to the amount of distinct proteins in a cell 
being dependent on the specialization of the cell, the abundance or concentration of each 
type of protein present is also dependent on the cell’s specialization.  For example, in a 
red blood cell, before the nucleus is expelled, the hemoglobin encoding segments of the 
cell’s DNA are highly expressed in the protein manufacturing process.  Due to a red 
blood cell’s high specificity, the cell is likely to have a relatively narrow distribution of 
distinct proteins.  In an adult red blood cell, hemoglobin accounts for roughly 90% of the 
cell’s dry weight, whereas other cells may have no single protein that accounts for more 
than 5% of the dry weight [3].  A cell in a stomach wall uses, to a larger extent than in 
other cells, segments of its DNA that create H+ gradient generating membrane proteins.  
Some cells, such as in glands, are specialized to create proteins that are excreted into the 
surrounding serum. 
 
2.2) TRANSCRIPTION AND TRANSLATION 
In order to protect the DNA, cells have evolved to use RNA to copy information from 
DNA through the process of transcription.  This allows the DNA’s information to be 
copied without the DNA having to leave the protection of the nucleus.  RNA polymerase 
copies the information from DNA to RNA through the mechanism shown in Figure 2.2.1.  
The RNA that contains the DNA’s information, known as messenger RNA (mRNA), 
     
   7
delivers the information to the ribosomes.  The ribosomes are the sites at which proteins 
are created within the cell.  The delivery of the DNA’s information in the form of mRNA 
to the ribosome then causes respective amino acids to be formed into a chain of amino 
acids.  Within the mRNA, specific triples of base pairs, called codons, correspond to each 
amino acid used by the ribosome in the synthesis of an amino acid chain.  Therefore the 
order of codons in the mRNA corresponds to the first order structure of the produced 
amino acid chain.  This amino acid chain, or peptide sequence, eventually grows longer 
until the process is complete, at which point the chain folds into a finished protein, 
sometimes referred to as a polypeptide.  It is through this process that the information 
encoded within DNA is used to make proteins; this process is called translation.  The 
following figure depicts the transcription of mRNA from DNA and the translation of 
information encoded in mRNA to the formation of proteins. 
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FIGURE 2.2.1:  Illustration of Translation of Information from DNA to Proteins* 
 
*Figure from [16] 
 
2.3) PROTEIN STRUCTURE 
Proteins have four orders to their structure: primary, secondary, tertiary, and quaternary.  
Primary order protein structure is the one-dimensional order of covalently bonded amino 
acids.  This order is a direct result of how the ribosome and the order of codons within 
the mRNA cooperatively construct the amino acid sequence.  There are 20 natural amino 
acids that can be used in the building of the first order structure of a protein.  Immediately 
after production by the ribosome, proteins are allowed to fold into higher order 
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conformations.  Secondary order protein structure involves the formation of localized 
structures, most commonly α-helices and β-pleated sheets.  These structures are the result 
of hydrogen bonding primarily between the carboxyl and amino groups of the peptide 
backbone.  Tertiary order protein structure is the folding of large sections of the peptide 
sequence.  The interactions that cause this are between the functional groups of the 
individual amino acids.  Covalent disulfide bonds are sometimes created between 
cysteine groups, greatly stabilizing the protein structure.  In water-soluble proteins, 
hydrophobic residues tend to group into the middle of a protein, leaving more hydrophilic 
residues exposed on the protein’s exterior.  In hydrophobic proteins, the hydrophilic 
residues group toward the protein’s interior leaving the hydrophobic residues exposed.  
Quaternary protein structure involves the grouping together of two or more polypeptides 
via noncovalent interaction to form an oligomer, such as the hemoglobin tetramer.  Not 
all proteins have quaternary structure.  For a protein to be able to perform its cellular 
function, all orders of its structure must be precise.  Factors such as temperature, pH, and 
the surrounding solvent can alter the higher order structure of a protein, thereby 
determining its biological activity or inactivity.  In 2D-LC-MS/MS, it is important to 
conserve only the first order protein structure during isolation, extraction, and separation, 
because MS cannot determine higher order structure.  However, the way a protein’s 
structure is changed must be consistent from run to run in order to ensure consistent 
digestion with enzymes and consistent retention in LC. 
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2.4) BIOLOGICAL ROLES OF PROTEINS 
Proteins are a useful class of molecules to study, because they carry out most of the 
functions within a cell.  Proteins are involved in many roles, including O2 transport, 
nuclear arrangement, transcription, DNA replication, translation, metabolic pathways, 
carbohydrate synthesis, and as enzymes [15].   It is because of this that differential 
expression of proteins can sometimes be correlated with the existence of certain diseases 
such as cancer.  
2.5) PROTEIN EXPRESSION DEPENDENCY ON DISEASE 
The protein expression within a cell is highly dependent on the specialization of the cell 
and therefore the cell’s location within the body.  In addition to protein expression 
differences due to cell specialization, the protein expression changes from normal to 
disease characteristic in certain disease states.  This change is in part due to the change in 
cell specialization due to the manifestation of a disease, because the cell’s surrounding 
environment and influences change in many disease states.  It has been shown that 
various types of cancer are accompanied by changes in protein expression and/or changes 
in modification of certain proteins.  A prime example of this is the change in histone 
acetylation in Chronic Lymphocytic Leukemia and Acute Meyloid Leukemia [21].  The 
offspring of each cell may also be influenced during cell division to conform to the 
disease state.  An example of this is a tumor.  Therefore, the protein expression from an 
entire area of cells in a patient with a disease may change from normal to disease-
characteristic expression.  This fact enables the use of analytical methods, namely 2D-
LC-MS/MS, for the determination of dependencies of protein expression on various 
diseases and establishment of protein profiles.  The following figure shows highly 
     
   11
simplified examples of how protein profiles might vary among patients with various 
cancers. 
FIGURE 2.5.1:  Example Relationships Between Disease and Protein Expression 
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3) PROTEIN ISOLATION 
Before 2D-LC-MS/MS can be used to characterize and identify proteins, proteins must be 
isolated from the patient.  It is crucial that the methods used to isolate proteins from the 
patient conserve the proportionality and relative abundances of proteins that exist in the 
tissue or serum.  Many factors must be considered in cell lyses, protein extraction, protein 
digestion, and all other sample preparation steps.  Since 2D-LC-MS/MS analyses are 
generally concerned only with the masses and sequences of polypeptides and proteins, 
the secondary and tertiary structures of these molecules need not be maintained in order 
to conduct faithful analyses.  Primary structure must be maintained, as this is what is 
being analyzed.  However, to maintain constancy of retention factors in LC, care must be 
taken to ensure that, for each polypeptide, there are no structural changes from run to run.  
Additionally, the quaternary structure of proteins must be considered during analysis.  
Because in-vivo protein higher-order structure need not be maintained, moderately harsh 
cell lysis and extraction techniques can be employed.  Since mammalian cells have no 
cell walls, their weak outer membranes can easily be disrupted [4].  The lysis of 
mammalian cells and the techniques used for lysis are not a major limiting factor for most 
protein extraction procedures.  Therefore, a wide range of lysis techniques can be used to 
suit the needs of the extraction. 
 
3.1) CELL LYSIS 
After cells are purified from a patient sample, they must be lysed before proteins can be 
extracted.   Common lysis techniques used for eukaryotic cells include osmotic shock, the 
use of detergent, enzymatic digestion, various types of homogenization, and grinding 
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with beads [4].  These techniques each have inherent drawbacks and advantages.  The 
technique of choice can be chosen depending on the type of cell to be analyzed and so 
that the lysis technique is compatible with the subsequent protein extraction technique.  
Osmotic shock, which breaks the exterior cell membrane by creating a level of osmosis 
that the membrane cannot tolerate, is unlikely to destroy the primary structure of any 
proteins and is unlikely lower any protein yield.  Grinding with beads and 
homogenization are relatively harsh, but are unlikely to negatively affect the yield of any 
proteins.  Using detergent disrupts the cell membrane by forming micelles with the 
membrane and removing sections of it.  Detergent methods are very likely to lower the 
yield of hydrophobic proteins, because many hydrophobic proteins, both within and 
attached to the cell membrane, are removed along with the micelles.  Enzymatic digestion 
as a lysis technique should be avoided, because the enzyme used may digest many of the 
proteins of interest, altering their primary structure.  If enzymatic digestion is to be used 
at all, it should be saved for downstream, where digestive enzymes can be used to 
systematically break down the proteins of interest in order to facilitate their primary 
structural analysis.  Therefore the methods of choice for animal cell lysis are osmotic 
shock, homogenization, and glass bead grinding, depending on the type of sample being 
analyzed—fibrous tissue samples may require homogenization for destruction of 
extracellular connections.   
 
3.2) PROTEIN EXTRACTION 
Different parts of an animal cell have different types of proteins.  Membranes within the 
cell contain mostly hydrophobic proteins.  The nucleus of a cell contains many basic 
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proteins [9,10,22].  The cytoplasm contains many hydrophilic proteins that can be either 
basic or acidic.  The properties of a protein vary depending on the location and function 
within the cell.  After a cell is lysed, the next step is extract proteins from the cell lysate.  
Major limiting factors for protein extraction procedures arise when multiple types of 
protein (i.e. - differences in hydrophobicity, pKa, or buffer solubility) are being extracted 
at one time.  Usually, an extraction procedure will focus on a select group of similar 
proteins, rather than trying to isolate all cellular proteins at once.  For example, to isolate 
the very hydrophobic membrane proteins, various micelle-forming detergents are used.  
These micelles solubilize the hydrophobic proteins but do not solubilize hydrophilic 
proteins.  To isolate nuclear proteins such as histones, various buffers are used to isolate 
cell nuclei, and an acidic reagent is then used to extract the selected basic proteins with 
minimal solubilization of DNA.  Beyond the differences in hydrophobicity, the pKa’s of 
proteins are a major factor in determining their solubility.  At a high pH, low functional 
pKa proteins will dissolve, and at a low pH, high functional pKa proteins will dissolve 
(the functional pKA is defined as the overall pKa of the protein).  Selectively dissolving 
proteins in an acid or base works efficiently for proteins containing many basic residues, 
lysine (K) and arginine (R), or many acidic residues, glutamic acid (E) and aspartic acid 
(D), because these groups have very high and very low pKa’s, respectively.  Basic 
proteins contain a high amount of K and R amino acids, and acidic proteins contain a 
high amount of D and E amino acids.  The following figure shows the deprotonation and 
hence changes in solubility for several groups of proteins.  Note that protein solubility is 
maximized when the protein molecule is most highly charged (when peptide residues 
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within the protein are charged) and that the peptide reactions shown can occur in multiple 
sites within a single protein. 
 
FIGURE 3.2.1:  Equilibria of Peptides and pH 
Basic Protein (high pKa): 
peptideH+      peptide + H+ 
low pH -----------------high pH 
 Intermediate Protein (intermediate pKa): 
  peptideH+      peptide + H+    OR    peptideH         peptide- + H+ 
         low-intermediate pH (~6)    intermediate-high pH (~8) 
Acidic Protein (low pKa): 
    peptideH         peptide- + H+ 
low pH------------------ high pH 
 
Extraction buffers’ salt concentrations also determine a polypeptide’s solubility due to 
changes in protein hydration with changes in the buffer’s ion concentration.  Usually, as 
the ion concentration of a buffer is increased, protein solubility is decreased.  The reason 
protein solubility decreases with increasing salt concentration is that the salt ions displace 
water molecules around the protein molecules and thereby compete with hydration of the 
protein.  This phenomenon is shown in terms of protein concentration vs. salt 
concentration in the following figure. 
 
 
     
   16
FIGURE 3.2.2:  Protein Solubility vs. Salt Concentration* 
 
*Figure from [11] 
 
To extract every protein from a cell, it is necessary to sweep a polarity gradient, a buffer 
concentration gradient, and a pH gradient.  Exposing all proteins within a cell lysate to all 
possible conditions (within appropriate ranges) will ensure that each protein has a chance 
to dissolve and thus be extracted.  The range of pH values to be tried should be roughly 
2-12, avoiding extremes in order to minimize unselective solubilization; many proteins 
are solubilized at extremes of pH [23].  The polarity gradient should consist of 100% 
water on one end and 100% of a much less polar solvent (i.e. - ethanol, propanol, or 
hexanol) on the other end.  The buffer concentration gradient should start with 100% 
water and end with roughly 1 M ammonium acetate.  It is important that all solvents and 
buffers be removable in order to be compatible with 2D-LC-MS/MS.  Dialysis 
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techniques, in which there is a pore size larger than the salt ions but smaller than the 
proteins, can later be used to remove salt from the proteins. 
 
3.3) PROTEIN DIGESTION AND SAMPLE PREPARATION 
This section investigates the details of protein digestion and discusses whether digestion 
need be used.  Digestion has advantages and disadvantages with regard to 2D-LC-
MS/MS analysis.  On one hand it fragments proteins extensively, thus assisting in a top-
down MS analysis of the resultant peptide fragments so that the exact location of 
modifications with a protein can be pinpointed.  On the other hand, the digestion can lead 
to relatively poor separation in cation-exchange chromatography and can be 
unpredictable.  In many cases protein digestion facilitates the analysis of the primary 
structure of large proteins.  In many cases an enzyme that always cleaves a protein at a 
certain amino acid, or type of amino acids, is used.  Trypsin is one such enzyme that 
cleaves proteins at positively charged residues, namely lysine and arginine.  Trypsin 
works well for basic proteins, which are full of these positively charged residues.  Due to 
the secondary, tertiary, and quaternary structures of many proteins, not all expected sites 
are cleaved by enzymes such as trypsin.  At very low concentrations of trypsin, the 
concentration is vaguely proportional to the amount of cleaved sites. 
 
For a given enzyme there is a focused type of protein that will be fragmented more than 
most others.  In the case of trypsin, which cleaves at positively charged sites, basic 
proteins are fragmented most.  Since trypsin is not completely efficient with respected to 
the number of expected sites cleaved, the charge distribution of the resulting fragments 
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from a highly basic protein might be something like: …-1, 0, +1, +2, +3,+4… at pH~7 
with the distribution being focused primarily at +1 and tapering off for charges further 
from +1.  The enzyme endoproteinase GluC cleaves proteins at negatively charged 
residues, namely glutamic acid and aspartic acid [5,6].  For endoproteinase GluC, the 
proteins that will be fragmented most are the acidic proteins, which contain more 
negatively charged residues than other proteins.  Since GluC also has limited efficiency, 
the charge distribution of the fragments from a very acidic protein digested by GluC 
might look something like: …-4, -3, -2, -1, 0, +1… at pH~7 with the distribution being 
focused primarily at –1.  For proteins that are neither very basic nor very acidic, the 
charges of the resulting fragments from a digestion with trypsin or GluC are more likely 
to be neutral as the positive and negative residues’ charges of a protein of neutral pKa are 
likely to cancel each other. 
 
Since the many proteins in a cell vary widely in pKa, the results of a trypsin digestion on 
a solution of all proteins from a given cell will vary greatly from protein to protein.  If all 
of the proteins are first digested and next have their pH lowered to 2, the resultant 
fragments will likely fall, for example, within the charge range 0 to +5, depending on the 
cleavage efficiency.  Note that the minimum charge here is 0, because it is assumed that 
if the pH is reduced to 2 all negatively charged residues will be protonated.  If none of the 
proteins are digested, the charge distribution of the proteins at pH~2 will likely range 
from 0 to +N, where N is the maximum combined number of arginine and lysine residues 
in a single protein molecule.  Since N is an order of magnitude or more greater than the 
highest charge on any one of the fragments resulting from digestion, the charge 
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distribution for undigested proteins is much wider than that for digested proteins.  Since 
the first dimension of 2D-LC-MS/MS uses cation exchange chromatography, better 
separation will be achieved if a wider charge distribution of proteins is present.  The 
following figures show hypothetical charge distributions for digested and undigested 
global protein samples at pH=2.  
 
FIGURE 3.3.1:  Model Charge Distribution for Digested Global Protein Sample 
Hypothetical Charge Distribution for Digested Global Protein 
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FIGURE 3.3.2:  Model Charge Distribution for Undigested Global Protein Sample 
Hypothetical Charge Distribution for Undigested Global Protein 
Sample (pH=2)
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Though protein digestion is useful in many techniques, there are several reasons why 
digestion need not be used in the process of establishing protein profiles.  As mentioned 
previously, cation exchange chromatography has a wider charge distribution from a 
global protein sample to separate if the proteins are left undigested.  Digestion of proteins 
is unpredictable, as many expected cleavage sites may remain uncleaved.  Also, the 
ability of protein profiles to identify diseases is likely to depend less upon the exact 
location within proteins of modifications and is likely to depend more on the abundance 
of modifications and proteins in general.  Therefore, establishment of reliable protein 
profiles via 2D-LC-MS/MS can be achieved best without digesting proteins. 
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4) INSTRUMENTATION 
4.1) LIQUID CHROMATOGRAPHY 
Chromatography in general involves separating different species of analyte by exploiting 
various properties of the analyte.  All chromatographic separations involve an analyte, a 
mobile phase, and a stationary phase.  The analyte is the sample to be separated.  The 
mobile phase is the solution the analyte is mixed with and transported by.  The stationary 
phase is usually composed of a solid medium with which the analyte can interact.  The 
mobile phase is usually varied so that at first the analyte is attracted more to the 
stationary phase than to the mobile phase solution.  As the run proceeds, the mobile phase 
becomes more accommodating to the analyte.  The disparity in properties among the 
analyte is necessary for separation to occur.  Properties typically exploited in 
chromatography include hydrophobicity, charge, affinity, size, and others.  The retention 
time of an analyte describes the comparative strength of the analyte-stationary phase 
interaction relative to the analyte-mobile phase interaction.   
 
Some key equations and terms involved in chromatography are: 
1) Retention time = time after injection for analyte to reach the detector 
2) Distribution Constant (K) = (concentration of analyte in stationary phase)/ 
(concentration in mobile phase) 
3) Selectivity Factor (α) = (Distribution constant for standard analyte)/ (dist. 
const. for other analyte).  This term describes how easily two analytes can 
be separated. 
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4) Number of theoretical plates (N) = (length of column)/ (theoretical plate 
height).  The number of theoretical plates is a measure of the efficiency of 
separation and is historically derived from the number of cells in a 
distillery column. 
5) Retention factor (k) = K*(Volume of analyte in stationary phase)/ (volume 
in mobile phase) 
6) Resolution (R) = √(N) / 4*( α -1)/ α *k/(1+k).  Resolution is defined as the 
separation between two peaks.  Two adjacent peaks that barely meet have 
a resolution of R=1. 
7) Van Deemter Equation:  H = A + B / u + C * u; H is the plate height, u = 
the linear velocity of the mobile phase, A = multiplicity of flow paths, B = 
longitudinal diffusion, and C = mass transfer between phases.  This 
equation links some typical chromatography variables to chromatic 
inefficiency.  The following figure displays the effects of each term to the 
plate height, which is inversely proportional to column inefficiency 
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FIGURE 4.1.1: Van Deemter Plot – Plate Height vs. Solvent Flow Rate* 
 
*Graph from [19] 
 
As can be seen in Figure 4.1.1, four terms contribute to the plate height.  ‘A’ describes 
the mobile phase’s and analyte’s ability to wind through multiple paths as they flow 
through a packing material.  ‘A’ is constant for a given column and decreases as columns 
with smaller inside diameters are used.  Because of this fact, column diameters as low as 
10 µm are used.  ‘B/u’ describes the diffusion along the column length of the analyte 
from the analyte’s elution zone into more dilute areas in front of and behind the zone.  
The effect of ‘B/u’ decreases as the flow rate of the mobile phase increases and as 
column length is decreased.  ‘C*u’ accounts for the fact that analyte mass can transfer 
between the stationary phases and the mobile phase occurs, and this process’s 
equilibrium speed is usually slower than the flow rate will allow for.  Therefore ‘C*u’ 
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accounts for the level of disequilibrium of the mass transfer.  ‘C*u’ has more of an effect 
at higher flow rates, because the equilibrium is more offset [14]. 
 
4.2) MASS SPECTROMETRY 
Several types of mass spectrometry (MS) exist.  Most applicable to protein 
characterization among these are ion-trap MS, Fourier transform ion cyclotron resonance 
(FT-ICR) MS, and time-of-flight (TOF) MS.  TOF-MS is typically used in experiments 
where the sample permits being immediately desorbed from a medium and ionized, as in 
matrix assisted laser desorption ionization (MALDI).  MALDI-TOF MS is very time 
consuming, because the protein sample needs to be separated prior to MALDI-TOF MS 
using a separate technique.  FT-ICR MS is useful in that it has detection limits down to 
attomolar concentrations of proteins, has very high sensitivity, and can identify up to 
20,000 components in a single mixture without prior separation [12].  FT-ICR MS is 
powerful enough to resolve isotopic distributions of analyte.  However, this quality of 
resolution is not necessary for establishing protein profiles, because differences between 
modified and unmodified proteins and differences between non-similar proteins can be 
resolved well enough with less resolution.  Ion trap MS is the MS technique most 
commonly used in 2D-LC-MS/MS due to its high stability and sufficient mass resolution 
(1 Da), limits of detection, and sensitivity [14].   
 
After chromatographic separation, protein ions are introduced to the mass spectrometer 
via electrospray ionization (ESI).  ESI works by having a high voltage (1-2 kV) potential 
applied to the protein-occupied solution at a capillary opening.  The capillary tubing’s 
     
   25
inside diameter should be decreased to such a small size that the capillary opening 
sufficiently resembles a point charge.  Decreasing the diameter of the capillary opening 
increases the efficiency of ionization of the solution, because there is more charge per 
unit volume.  ESI is a necessary interface between chromatography and MS, because it 
converts proteins into highly charged forms and desolvates the proteins.  It is necessary 
that the proteins have a high charge, because MS is selective of mass/charge (m/z) ratios.  
If none of the proteins were charged, there would be no m/z ratio, and more importantly, 
there would be no selectivity of mass analysis between different proteins.  It is necessary 
that the proteins be desolvated, because having solvent molecules variably attached to the 
proteins creates much more complex mass spectra and becomes very confusing to 
deconvolute. 
 
Just as chromatography is selective of certain molecular properties, MS is selective of the 
m/z ratio of the ions introduced into the MS system.  An ion trap MS uses two ring 
electrodes, which are charged with an alternating radio frequency (RF), to excite the 
analyte ions.  To either side, between the ring electrodes, are grounded electrodes, usually 
referred to as end-caps.  An RF range is scanned so that at lower RF, lighter ions oscillate 
with a stable orbit, and at higher RF, heavier ions oscillate with a stable orbit [14].  As 
ions’ orbits become unstable, they collide with one of the end-caps, causing an electrical 
discharge.  The current from this discharge is detected, multiplied using an electron 
multiplier transducer, and measured using a computer to form a signal for each ion [14].  
Comparison of each ion signal with the RF value at which the ion collision occurred 
provides the user with an abundance vs. m/z spectrum.  To obtain MS/MS data for a 
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given ion, one can freeze the RF scan in the quadrupole analyzer at a particular RF at 
which the parent ion of choice has a stable oscillation.  An inert gas such as helium is 
introduced, and collisions between the parent ion and the gas molecules occur, causing 
the ion to fragment into smaller daughter ions.  These daughter ions can then be measured 
by sweeping the ring electrodes through an RF range and collecting m/z data in the same 
manner as for the parent ion.  MS/MS data can be collected for a given ion within a small 
number scans.  The ease with which one can fragment a certain m/z protein and collect 
daughter ion mass spectra with an ion trap MS makes ion trap MS the method of choice 
for establishing protein profiles and related daughter ion data.   
 
Most ion trap MS instruments contain a quadrupole mass analyzer that proceeds the ion 
trap analyzer.  The quadrupole mass analyzer works in a method similar to that of the ion 
trap.  In a quadrupole, there are four electrically conductive rods, each exposed to an 
alternating RF frequency.  Rods opposite from each other are electrically connected.  
Two of the rods are connected to the positive side of a direct current source, and the other 
two rods are connected to the negative side of the direct current source.  Alternating RF 
currents are exposed to the two pairs of rods and are 180° out of phase with each other 
[14].  As in ion trap MS, only ions with a certain m/z value remain in a stable orbit at a 
given moment in time.  In most MS/MS experiments, the quadrupole analyzer is used to 
focus on a parent ion, and the ion trap analyzer is used to analyze the subsequent 
daughter ions.  The following figure shows a quadrupole mass analyzer and an ion trap 
mass analyzer: 
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FIGURE 4.2.1:  Ion Trap and Quadrupole Mass Analyzer Diagrams* 
 
*Picture from [20] 
 
4.3) 2D-LC-MS/MS 
2D-LC-MS/MS incorporates two types of chromatographic separation and tandem mass 
spectrometry in one automated process.  The two types of separation are ion exchange 
and reversed-phase (RP) separation.  The type of ion exchange chromatography used 
depends on the pH of the mobile phase used during separation.  For low pH, strong cation 
exchange (SCX) chromatography should be used, because most proteins are protonated 
and are thus positively charged (cations) at a low pH.  Anion exchange chromatography 
is used if the mobile phase is held at high pH, because most proteins are deprotonated and 
are thus negatively charged (anions) at high pH.  In SCX, analyte in the form of cations is 
introduced to a chromatographic column with immobilized anionic functional groups.  
     
   28
The cations have affinity for the immobilized anionic functional groups and are thus 
retained on the column.  As increasing concentrations of salt are introduced to the 
column, salt cations compete with the analyte cations for binding to the anionic column, 
and analyte cations are selectively eluted.  Analyte cations with lower charge are eluted 
first.  Selectivity of the analyte cation elution is primarily based on differences in charge.  
Further selectivity of analyte cation elution is based on size and polarity.  2D-LC-MS/MS 
will be discussed in terms of SCX with mobile phase solvents at low pH.  In RP 
chromatography, the second separation dimension of 2D-LC-MS/MS, the analyte is 
injected onto the column, and the solvent generally shifts from water (most polar) to an 
organic solvent (less polar).  As the solvent gradient shifts toward less polar, the analyte 
desorbs from the stationary phase and elutes, more polar analyte eluting first. 
 
Typical mobile phase compositions used in RP separation of proteins or peptides are: 
Solvent A, water with .1% formic acid; Solvent B, acetonitrile with .1% formic acid.  
Trifluoroacetic acid (TFA) is used in place of formic acid (also at .1%) in many cases.  
TFA or formic acid, which lower pH, are added to the mobile phase in chromatography, 
because their anionic species bind (ion-pair) with the cationic protein species (many 
proteins are cationic at low pH), thereby neutralizing proteins, markedly decreasing 
solubility, and increasing column retention.  If ion-paring species such as formic acid or 
TFA were not used, most cationic proteins would be lost.  TFA induces better separation 
through this mechanism than does formic acid.  However, formic acid is much more 
compatible with MS, because it is more easily desolvated during ESI, allowing positive 
ions to form.  The lowering of pH that accompanies the use of an ion-pairing agent 
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should also lower the solubility of acidic proteins, thereby increasing retention of as 
many proteins as possible. 
 
Typical mobile phase compositions used in SCX separation of proteins or peptides are: 
Solvent A, water; Solvent B, 500mM ammonium acetate in water.  In addition to having 
a suitable cation upon dissociation, ammonium acetate is chosen because it is sufficiently 
volatile that it does not cause significant interference in MS.  It is likely that the use of 
TFA and formic acid have devastating effects in SCX separation, because their ion-
pairing action will neutralize many of the positive charges of the proteins, thereby 
eliminating protein affinity for the anionic SCX column.  The facts that ion-pairing 
agents are necessary in RP chromatography and that ion-pairing agents cannot be used in 
SCX chromatography, presents a major incompatibility between the two methods.   
 
To overcome this incompatibility between SCX and RP separation, four pump systems 
can be used where SCX separation occurs without an ion-pairing agent being present, and 
RP separation occurs with the ion-pairing agent present.  This method allows the analysis 
of peptides resulting from protein digestion.  The following figure depicts a typical four 
pump 2D-LC-MS/MS system. 
 
 
 
 
 
     
   30
FIGURE 4.3.1:  Four Pump 2D-LC-MS/MS Schematic* 
 
*Figure from [15] 
 
 
Another possible method requires that the proteins to be analyzed are not digested.  The 
idea here is that the charge distribution of proteins will be so wide and contain high 
enough protein charges that the presence of an ion-pairing agent will not significantly 
shrink the charge distribution of proteins.  This method allows the use of only three 
pumps, because the addition of a fourth pump with water free of ion-pairing agent is not 
necessary.  This reduces overall costs in owning and operating a 2D-LC-MS/MS system 
and greatly simplifies the method used.  The following figure shows the 2D-LC-MS/MS 
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system in which: proteins should not be digested prior to analysis, only three pumps are 
needed, and ion-pairing agents can still be used.  The mobile phase compositions in this 
picture are: Solvent A, water with .1% formic acid; Solvent B, acetonitrile with .1% 
formic acid; Solvent C, 500 mM ammonium acetate in water. 
 
FIGURE 4.3.2:  Three Pump Linear Column 2D-LC-MS/MS Schematic 
 
 
In this system, the analyte is loaded in solution into the sample loop, which ensures that 
the sample injection volume is the same from run to run.  The analyte is then washed in 
the first C18 column so that all salts from extraction procedures are removed from the 
sample.  An increase in acetonitrile concentration then washes the analyte to the SCX 
column, where the cationic proteins are retained.  At this point, the salt concentration 
(Solvent C) in this 2D-LC-MS/MS system is increased in a stepwise fashion to elute in 
steps cationic proteins of increasing charge from the SCX column.  After each step in salt 
concentration increase, a polarity gradient starting with ~95% water and ending with 
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~90% acetonitrile is intermittently run.  This polarity gradient separates proteins on the 
final C18 column.  The following figure shows an example of a 2D-LC-MS/MS gradient. 
 
FIGURE 4.3.3:  2D-LC-MS/MS Solvent Control Diagram 
 
 
4.4) ADVANTAGES OF 2D-LC-MS/MS OVER LC-MS/MS 
2D-LC-MS/MS has some important advantages over one-dimensional liquid 
chromatography - tandem mass spectrometry (1D-LC-MS/MS or LC-MS/MS) in the 
analysis of very complex mixtures such as protein mixtures obtained via global protein 
extraction from cells.  Generally speaking, 2D-LC exploits more properties of protein 
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mixtures and peptide mixtures than does 1D-LC.  Whereas RP chromatography only 
utilizes differences in polarity and size of the analyte, 2D-LC exploits these features and 
differences in the charge among the analyte.  The result of having more methods of 
separation is having a higher amount of separation.  A mixture of proteins that is grouped 
together as one peak in 1D-LC is likely to be separated into multiple peaks in 2D-LC.  
Perhaps the only disadvantage of 2D-LC is the large amount of time required for a single 
run.  However, when considering that each protein to be separated requires a certain 
amount of time, or peak width, and that more time is used in 2D-LC, the peak capacity in 
2D-LC is on the order of magnitude of 10X higher than in 1D-LC.  The advantages of the 
higher degree of separation and increased peak capacity in 2D-LC far outweigh the 
disadvantage of longer run time.  The results of having a higher degree of separation are 
that it becomes much easier for MS and MS/MS to resolve proteins from one another and 
to identify which daughter ion fragments are from which parent ion proteins, 
respectively.  Chromatograms of trypsin digested peptide fragments separated using 1D-
LC-MS/MS (figure 4.4.1-a) and 2D-LC-MS/MS (figure 4.4.1-b) are shown below.  
Figure 4.4.1-b also shows the salt gradient (spikes) and acetonitrile gradient (ramps) in 
the background.  Bear in mind that the 2D-LC-MS/MS chromatogram is stretched over 
~700 min, whereas the 1D chromatogram is only ~100 min in duration.  Additionally, 
note that the 2D-LC-MS/MS separation would most likely be better if the original 
proteins had not been digested, because the charge distribution would be much wider. 
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FIGURE 4.4.1:  Chromatograms for 1D-LC-MS/MS and 2D-LC-MS/MS 
a)  1D-LC-MS/MS 
 
 b)  2D-LC-MS/MS 
 
 
5) NON-DISEASE-SPECIFIC VARIABILITY OF SAMPLES 
For each disease, there is an optimal place within the human body where the 
consequential differences in protein expression are most prominent.  For example, liver 
cancer’s manifestation can best be seen in the liver, and samples taken from the liver will 
best show the differences in protein expression due to this disease.  Since diseases each 
have their own ideal sampling locations within the body, there will be a great deal of 
variability in non-disease-specific protein expression due to the differing specialization of 
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cells in different areas of the body.  When creating protein profiles whose differences 
correspond only to the effects of each disease, it is necessary to eliminate any differences 
among profiles that are due to sampling location.  One method to solve this problem is to 
establish blank (disease-free) protein profiles for all areas of the human body that will be 
tested and establish standard deviation values for all natural proteins at each of these 
areas.  Additionally, blank protein profiles can be created for modifications in the 
procedure, such as use of different solvents, enzymes (if digestion is preferred), or protein 
extraction techniques.  Once many blank profiles and disease-state profiles are created, 
statistical validation techniques can be used to determine what differences in protein 
profiles are due to cell specialization and what differences are due to diseases.  When 
protein profiles from patients are compared with database protein profiles, match results 
will be most statistically credible for the patient’s profile whose procedure was most 
similar to the procedure most commonly used to obtain database protein profiles.  For the 
patient whose protein profile is obtained using non-standard techniques, the results will 
be less credible, because there will be fewer database protein profiles whose methods 
were the same.  At first glance this seems like a major drawback, but as more protein 
profiles obtained by various methods are added to the database, more credibility will be 
associated with each method.   
 
6) DATABASE AND SEARCH TOOLS 
Due to the immense amount of variability in non-disease-specific protein expression and 
in protein isolation techniques, it is critical that the database and search tools used to 
handle protein profiles be sensitive to and aware of these experimental differences.  
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Sources of non-disease-specific variability from experiment to experiment in protein 
profiles include: different lysis procedures, different sources of sample (i.e. – tissue, 
serum), different instrumentation, different solvents in LC, different extraction 
procedures, whether the protein sample was digested, biological differences between 
subjects such as race or gender, and many other factors.  To account for the many 
differences in methods used, as much information as possible must be included for each 
protein profile on the database.  It is thus necessary to have a program with input values 
for all of the different parameters that pertain to each experiment.  Having a 
computational method for determining the relevancy of differences of experimental 
parameters among experiments will provide one with many bases for determining 
statistical relevancy between profiles.  In such a computational method, ranges of 
numerical values can be assigned to the ranges possible for given parameter.  For each 
parameter there is a group of certain ranges of numbers.  The user’s input through the 
user interface will determine what value among the range of possible values will be used 
for the parameter in question.   
 
As a specific example, consider a case when the user uploads a protein profile and selects 
“adult red blood cells” within the “Select Body Location, Sample Type, Ethnicity, and 
Gender from List” option available on the program.  For this selection, a numerical 
sample type value of 3 points is assigned to the protein profile.  The range of sample type 
values extends from 0 to 10 points, where the values indicate, with roughly linear 
estimation, the amount of distinct proteins available in the sample.  Since adult red blood 
cells have relatively few distinct proteins, a low value of 3 is given to the profile.  A 
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protein profile obtained from skin cells or muscle cells might receive a higher value, such 
as 7 out of 10 possible points.  A profile obtained from glandular cells might receive a 
value of 10 out of 10 points due to optimal distinct protein content.  As the value 
increases, a higher amount of distinct proteins is expected to be present and a higher 
signal to noise ratio is thus expected.  Therefore the protein profile associated with a 
higher value can be given a higher confidence level in terms of accurate representation of 
the disease state in question.  In addition to a rating of the amount of distinct proteins, 
many other factors can be associated with the sample type and can be given respective 
numerical values and possible ranges.  This type of number/range assignment can be 
given to each parameter input in the program.  The following figure shows a rudimentary 
program for the input of sample and experiment associated data and the uploading of 
experimentally obtained protein profiles: 
 
FIGURE 6.1: Example Program for Profile Uploading and Parameter Input 
 
Select Body 
Location, 
Sample Type, 
Race, and 
Gender from 
List 
Upload 
2D-LC-MS/MS 
Protein 
Profile(s) 
Select 
Homogenization 
and Lysis 
Procedure(s) from 
List 
Select Diseases for Comparison 
(More Diseases Cost More Time) 
or Enter Suspected Disease 
Select pH Minimum 
and Maximum or 
Specific Values Used 
in Protein Extraction 
Select Buffers Used 
for Salt-Protein 
Solubility Extraction 
Select Solvents Used for 
Polarity Difference 
Protein Extraction 
Select Enzyme Used 
for Digestion and 
Concentration 
Added, or No 
Digestion? 
Select Positive or 
Negative Ion Mode 
Select Instrument 
Used for Analysis 
Select Solvents 
Used in 2D-LC-
MS/MS, Sample 
Injection Volume, 
and Estimated 
Overall Protein 
Concentration 
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The database used to hold the protein profiles will grow as more protein profiles are 
added.  Therefore, for any given method used, for any part of the body sampled, and for 
any disease, the statistical basis for any decision will increase as time progresses.  In 
order for this to happen, each protein profile compared with the database must eventually 
be added to the database along with an official determination of the disease that 
corresponds to each profile.  In some cases, the addition of the profile to the database 
may take awhile, because it is necessary to first determine whether the patient does or 
does not in fact have the disease.  Alternatively, each database protein profile could have 
a relative certainty value attached to it that describes the amount of certainty that the 
profile is related to a certain disease.  Each time a patient’s profile is compared with the 
database, the amount of certainty of each database profile will determine the amount of 
association between the profiles for a given disease.  The relative certainty value for a 
profile could later be updated if it was later determined that the patient definitely does or 
does not have the disease.  The following diagram demonstrates one possible method for 
data flow in protein profiling. 
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FIGURE 6.2:  Proposed Schematic for Database Interface and Data Analysis 
 
To increase the certainty of a profile and create more routes for association between 
similar profiles, the daughter ion spectra of the original profiles can be used for more in 
depth analysis.  In this scenario, the MS (parent ion) data are used to create the protein 
profiles.  When a match is made for a profile to another group of profiles within a 
predetermined threshold of certainty, the MS/MS (daughter ion) data from each profile 
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can then be compared to determine a new level of certainty of the match.  Through this 
method the errors associated with protein profiling can be minimized to a great extent, 
depending on the amount of MS/MS data available.  The following figure illustrates the 
process by which profiles are obtained and the process by which MS/MS data can be 
used to increase confidence levels of a given match: 
 
FIGURE 6.3:  Flowchart of Information from Patient to Disease Association 
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7) CONCLUSIONS 
In order to easily compare the underlying traits of one disease to those of another, it is 
necessary to have a standardized method of obtaining the diseases’ information.  
Otherwise, comparison of multiple research groups’ data would either be inconclusive or 
be very difficult to conduct due to the massive incompatibilities of one method to 
another.  Additionally, a single person can understand only a limited amount of 
information, and fully understanding the results obtained via many different methods is 
very time and energy consuming.  Using bioinformatics is a solution that many research 
groups are turning to, because letting computers do as much work and data analysis as 
possible allows scientists to continue leading study and resources into uncharted areas of 
research.  This is a trend that has been observed in the computer industry for the last 40 
years or more.  As computational widgets achieve higher and higher ability, more and 
more computational work that would otherwise be done by people is done by computers. 
 
In terms of developing a standardized method for analyzing protein profiles from various 
diseases, 2D-LC-MS/MS provides many characteristics necessary for such a purpose.  
2D-LC-MS/MS is very fast in comparison with traditional techniques such as gel 
electrophoresis and immunoassay techniques.  2D-LC-MS/MS has the potential to 
measure a very large amount of proteins from a single sample.  2D-LC-MS/MS provides 
a large amount of information relative to the information encoded within a given sample.  
This is possible due to MS/MS analysis of daughter ions, the ability to measure many 
different proteins, and the ability to use information about retention in 2D-LC in 
coordination with MS data to statistically validate findings. 
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The growth and proliferation of the protein profile database and associated programs will 
likely be characterized by: enormous compilation of protein profiles for each disease, 
consideration of more and more experimental and sample parameters, addition of new 
computational values and ranges associated with each parameter, extra MS/MS data, and 
increased match-certainty determination capabilities.  It would not be surprising if such a 
database grew to contain many terabytes of useful information as research groups and 
medical institutions all start to contribute protein profiles and profile comparison ideas.  It 
is necessary that the database and associated programs be fluidic, allowing acceptable 
user-induced changes to be made.  Therefore, this database and associated programs 
would serve not only as a key for identification of certain diseases like cancer but also as 
a method to uptake and exercise new paradigms and methods in protein analysis.  As 
more and more protein profiles are analyzed, it is likely that many more proteins will be 
discovered, thereby leading to further coverage of the human proteome. 
 
8) SOME PERSONAL PROTEOMIC RESEARCH CONTRIBUTIONS 
8.1) 2D-LC 
During the development of the 2D-LC-MS/MS system, multiple considerations needed to 
be taken, and many problems were overcome.  Considerations included what type of 
column packing materials to use, what plumbing and system control configurations to 
use, what solvents should be used, compatibility between SCX and reversed phase 
chromatography, and many others.  Some of the problems that arose included lack of 
analyte retention in the SCX column, salt removal, poor initial separation, and difficulty 
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obtaining reproducibility.  The problem with lack of analyte retention was solved by the 
addition of a C-18 trap column prior to SCX separation.  The trap column removed salt 
from the sample prior to SCX introduction, and the lack of salt in the sample thereby 
allowed the analyte to be retained by the SCX column.  It was therefore found that salt 
must be removed prior to SCX introduction, because the presence of salt interferes with 
the retention of the analyte in the column.  Difficulties in obtaining reproducibility were 
partially overcome by the simplification of the 2D-LC/MS setup.  Finding an optimal 
solvent gradient method increased the degree of separation of peptides in 2D-LC.  Many 
issues were confronted and overcome in terms of making the 2D-LC method compatible 
with the MS method and protein extraction methods. 
 
8.2) COLUMN PACKING 
In order to develop functional columns for 1D and 2D-LC that could be made to any 
length or inside diameter or packed with any packing material, a column packing 
procedure was used for the packing of the columns used in our experiments.  The setup 
involved a pressure chamber with a vial inside of it.  Inside the vial was a packing 
material slurry, stirred by a magnetic stir-bar.  One end of the capillary used to make the 
column was submerged in the vial, and the pressure inside the bomb was increased.  The 
packing material from the slurry entered the capillary and traveled until it was stopped by 
a micro-filter or frit at the end of the capillary.  Many arrangements were tried in the 
packing of columns.  The type of filters/frits used to retain the packing material, the 
pressure used for column packing, the type of packing material, the solvents used to 
develop packing material slurries, the inside diameter and length of columns, and the 
     
   44
physical arrangement of the column packing procedure were all parameters that were 
adjusted to obtain ideal columns.  Criteria used to assess the quality of a packed column 
were homogeneity, retention of analyte, and reproducibility in experiments. 
 
8.3) LC METHODS 
It was found that the speed of separation of bovine histones using an HPLC could be 
increased significantly by slightly altering the solvent gradient method used in separation.  
Since there were large gaps of time between peaks in the HPLC histone chromatograms, 
higher slopes of solvent percentage per time were used during these gaps.  Therefore the 
elution time of many of the histones were decreased while the efficiency of the separation 
process was not compromised.  The faster solvent gradient method that I developed is 
now in use in Dr. Michael Freitas’ laboratory today. 
 
8.4) CAPILLARY ELECTROPHORESIS 
Many research hours were spent trying to interface a capillary electrophoresis instrument 
(CE) with an FT-ICR mass spectrometer via ESI to form the type of setup commonly 
referred to as CE-MS.  There was no method for detection of analyte in the CE via UV or 
fluorescence, and therefore MS was the only possible method of detection with the 
available resources.  In an improvised setup, I altered the electrical configuration of the 
CE to externalize much of the CE circuit and capillary and couple them with the ESI 
segment of the overall CE-MS setup.  This project, though very educational, was a failure 
in terms of actual results. 
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8.5) ESI INTERFACING 
During my research, I developed ESI tips and complex physical platforms for LC-MS 
interfacing.  Factors that need to be considered in tip-making are the inside diameter at 
the tip, smoothness of the tip, and what method to use.  The methods I used in tip making 
were pulling tips under flame, pulling tips in the presence of a very thin strip of ignited 
magnesium, and grinding tips with a diamond coated grinder.  Tips made by the grinding 
method worked somewhat well, however were susceptible to instability of spray.  These 
tips also did not have narrowed tips, which are necessary to mimic a point charges in ESI.  
Tips made by pulling capillaries over flame did have a narrowed diameter and therefore 
were better at mimicking point charges in ESI.  However, the reproducibility obtained 
with these tips was poor due to variation in the result of the pulling process.  Pulling tips 
in the presence of burning Mg was found to mimic a point charge better than either of the 
other methods in some cases and was found to create quickly tapered tips in some cases, 
because the presence of a thin sliver of very high temperature concentrated the heat in a 
small distance on the capillary.  The Mg strip method, however, was not very 
reproducible due to the very high temperature involved. 
 
In order to connect LC and CE techniques with MS via ESI, multiple physical ESI 
platforms were made.  I designed platforms to conform to critical sizes required by 
connection locations on MS instruments and to conform to the necessary functions of 
holding the ESI and CE electrodes, holding columns and capillaries, and maintaining 
rigidity.  The parts I drafted, using drawings and dimensions, were machined by the OSU 
Chemistry Dept. machine shop and are used in Dr. Michael Freitas’ laboratory today. 
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